Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K
Current Trends in Nursing I01:28

Current Trends in Nursing I

5.5K
Current trends in nursing include:
5.5K
Current Trends in Nursing II01:30

Current Trends in Nursing II

3.6K
Trends in nursing are multifactorial and associated with changes in society, within the nursing profession, and in other professions. Notably, telehealth and remote nursing contribute to successful healthcare delivery for numerous patients and help reduce stress for nurses due to nursing shortages. Nurses can reach patients, monitor their conditions, and interact with them using computers, audio, visual accessories, and telephones—for example, remote patient monitoring systems. Likewise,...
3.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.3K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.3K
Gene Therapy00:59

Gene Therapy

27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient perspectives on clinicians' use of ambient AI scribes.

JAMIA open·2026
Same author

A case of an incomplete congenital sciatic artery with aberrant central venous anatomy.

Journal of vascular surgery cases and innovative techniques·2026
Same author

Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patients.

Journal of neuro-oncology·2026
Same author

Case-control study of risk determination for obstetric postpartum venous thromboembolism.

Vascular medicine (London, England)·2026
Same author

Development and external validation of prediction models for major osteoporotic fracture and hip fracture in people with intellectual disability.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Results of the American Venous Forum research retreat on C2 disease confirms that the biology of varicose veins including etiology, progression, and novel therapeutics, as well as disparities, are top research priorities.

Journal of vascular surgery. Venous and lymphatic disorders·2026

Related Experiment Video

Updated: Feb 13, 2026

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

8.9K

New Trends in Anticoagulation Therapy.

Margaret Smith1, Glenn Wakam1, Thomas Wakefield2

  • 1General Surgery Residency, Department of Surgery, University of Michigan, 2207 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-5867, USA.

The Surgical Clinics of North America
|March 6, 2018
PubMed
Summary

New direct oral anticoagulants and reversal agents are transforming anticoagulation pharmacy. Current trends focus on extended therapy for venous thromboembolism (VTE) and thromboprophylaxis in high-risk patients.

Keywords:
AnticoagulationDeep venous thrombosisDirect oral anticoagulantsPerioperative bridgingVTE chemoprophylaxisVTE extended therapyVenous thromboembolism

More Related Videos

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.4K
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

1.0K

Related Experiment Videos

Last Updated: Feb 13, 2026

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood
07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

8.9K
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
11:17

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood

Published on: October 12, 2012

14.4K
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
07:50

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study

Published on: April 18, 2025

1.0K

Area of Science:

  • Pharmacology
  • Hematology
  • Clinical Pharmacy

Background:

  • The landscape of anticoagulation has significantly evolved with recent FDA approvals.
  • Direct oral anticoagulants (DOACs) and novel reversal agents are now central to clinical practice.

Purpose of the Study:

  • To review current trends in anticoagulant selection for venous thromboembolism (VTE).
  • To discuss advancements in anticoagulant reversal and bridging strategies.
  • To explore evolving approaches to extended VTE therapy and thromboprophylaxis.

Main Methods:

  • Analysis of recent clinical trial data and FDA approvals.
  • Review of current practice guidelines and emerging trends.
  • Examination of risk stratification tools like the HERDOO2 system.

Main Results:

  • Five DOACs and two novel reversal agents have been approved, altering treatment paradigms.
  • Extended therapy for unprovoked VTE now includes low-dose DOACs, aspirin, and risk-stratified discontinuation.
  • Low-dose DOACs are increasingly used for extended thromboprophylaxis in high-risk patients.

Conclusions:

  • The practice of anticoagulation is rapidly changing due to new pharmacotherapies and evidence.
  • Personalized approaches, including risk assessment and extended therapy, are key to optimizing VTE management.
  • DOACs represent a significant advancement in both treatment and prevention of VTE.